Title

Gender differences in acetaminophen-induced acute liver failure

Document Type

Conference Proceeding

Publication Date

2019

Publication Title

Acad Emerg Med

Abstract

Background: The rate of acetaminophen-induced acute liver failure (Apap-ALF) has risen substantially. Our primary objective was to test differences in presentation and outcomes of Apap-ALF based on gender. We secondarily tested whether obesity may affect survival. Methods: We performed a retrospective observational study inclusive of Apap-ALF cases over a 12-year period from a regional transplant center. All case data was composed with standardized data collection tools by trained abstractors. We defined ALF by the presence of AST and ALT ≥ 1000 U/L and an INR ≥ 2.0. We excluded cases without Apap ingestion. Univariate analysis compared clinical characteristics and 28-day transplant-free survival based primarily on gender. We also performed multivariate logistic regression to include obesity (body mass index > 30), age, and sequential organ failure assessment (SOFA) score. Results: There were 327 patients included, of whom most were female (67%). Women had similar age (39 ±14 vs. 40 ±16 years) and comorbidities to men, but were less likely to have a history of alcohol use (34% vs. 63%, p<0.001), less likely to abuse street drugs (12% vs 23%, p=0.014), and more likely to have chronic pain (51% vs. 34%, p<0.001). Apap-opioid combinations were common causes of ALF in both genders (54% of men vs. 57% of women, p=0.38). Women had lower mean initial SOFA scores than men (19.5 vs. 22.0, difference 2.4, 95% CI -0.1 to 4.9). They also had lower MELD scores at 48-hours (24 vs. 28, difference 4, 95% CI 1 - 7). Transplant was performed in 6 patients, all of whom were women. Substance abuse was less commonly a reason for transplant denial in women (19% vs 29%, p=0.06). Females had higher rates of transplant free survival (76% vs. 67%, p=0.013) at 28-days compared to men. Nevertheless, in adjusted analysis, only age was significantly associated with transplant free survival (OR per 1-year increase in age 0.97, 95% CI 0.95 - 0.98). The OR (95% CI) for female gender was 1.5 (0.86-2.5), for obesity 1.5 (0.78 - 2.7), and for 1-point increase in SOFA 0.99 (0.97-1.0). Conclusion: In this study, women accounted for the majority of patients with Apap-ALF and had lower severity of illness compared to men. Women were less likely to be denied transplant for substance abuse.

Volume

26

First Page

S171

This document is currently not available here.

Share

COinS